Howard Hughes Medical Institute’s Thermo Fisher Scientific TMO Stock Holding History

Howard Hughes Medical Institute’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-81	Closed	-$46.9K	–	434
2025 Q4	$46.9K	Sell	81 -1	-1%	-$566	0.03%	43
2025 Q3	$39.8K	Hold	82	–	–	0.02%	54
2025 Q2	$33.2K	Buy	+82	New	+$34.3K	0.01%	64
2023 Q1	–	Sell	-20,000	Closed	-$11M	–	17
2022 Q4	$11M	Hold	20,000	–	–	6.13%	3
2022 Q3	$10.1M	Hold	20,000	–	–	2.88%	13
2022 Q2	$10.9M	Hold	20,000	–	–	5.87%	5
2022 Q1	$11.8M	Hold	20,000	–	–	5.18%	7
2021 Q4	$13.3M	Hold	20,000	–	–	5.23%	5
2021 Q3	$11.4M	Hold	20,000	–	–	3.85%	9
2021 Q2	$10.1M	Hold	20,000	–	–	3.37%	13
2021 Q1	$9.13M	Hold	20,000	–	–	3.11%	13
2020 Q4	$9.32M	Hold	20,000	–	–	2.18%	12
2020 Q3	$8.83M	Sell	20,000 -5,000	-20%	-$2.07M	2.9%	12
2020 Q2	$9.06M	Hold	25,000	–	–	3.7%	7
2020 Q1	$7.09M	Sell	25,000 -5,000	-17%	-$1.58M	1.49%	13
2019 Q4	$9.75M	Hold	30,000	–	–	3.49%	5
2019 Q3	$8.74M	Hold	30,000	–	–	2.45%	7
2019 Q2	$8.81M	Hold	30,000	–	–	4.21%	3
2019 Q1	$8.21M	Hold	30,000	–	–	1.91%	6
2018 Q4	$6.71M	Hold	30,000	–	–	2.13%	9
2018 Q3	$7.32M	Hold	30,000	–	–	2.14%	9
2018 Q2	$6.21M	Hold	30,000	–	–	1.57%	10
2018 Q1	$6.19M	Hold	30,000	–	–	1.61%	11
2017 Q4	$5.7M	Hold	30,000	–	–	1.48%	14
2017 Q3	$5.68M	Hold	30,000	–	–	1.41%	14
2017 Q2	$5.23M	Sell	30,000 -10,000	-25%	-$1.68M	0.95%	25
2017 Q1	$6.14M	Hold	40,000	–	–	1.13%	20
2016 Q4	$5.64M	Hold	40,000	–	–	1.29%	21
2016 Q3	$6.36M	Hold	40,000	–	–	1.64%	18
2016 Q2	$5.91M	Sell	40,000 -5,000	-11%	-$738K	1.99%	14
2016 Q1	$6.37M	Sell	45,000 -5,000	-10%	-$670K	1.4%	16
2015 Q4	$7.09M	Sell	50,000 -286	-0.6%	-$38.1K	1.08%	13
2015 Q3	$6.15M	Sell	50,286 -4,905	-9%	-$639K	1.15%	14
2015 Q2	$7.16M	Sell	55,191 -4,425	-7%	-$577K	1.52%	9
2015 Q1	$8.01M	Sell	59,616 -3,447	-5%	-$444K	1.09%	11
2014 Q4	$7.9M	Sell	63,063 -8,214	-12%	-$999K	2.11%	11
2014 Q3	$8.67M	Buy	71,277 +2,720	+4%	+$331K	1.93%	7
2014 Q2	$8.09M	Sell	68,557 -1,443	-2%	-$170K	1.36%	8
2014 Q1	$8.42M	Sell	70,000 -15,000	-18%	-$1.78M	1.19%	8
2013 Q4	$9.46M	Sell	85,000 -997	-1%	-$99.1K	1.43%	8
2013 Q3	$7.92M	Buy	85,997 +13	+0%	+$1.18K	1.21%	9
2013 Q2	$7.28M	Buy	+85,984	New	+$7.16M	2.4%	9

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Howard Hughes Medical Institute's TMO Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 81 shares — an estimated $46.9K sold.

Howard Hughes Medical Institute first reported a position in TMO in Q2 2013 and held it in 42 quarters. The position peaked at $13.3M in Q4 2021. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 81 Thermo Fisher Scientific shares in Q1 2026, an estimated $46.9K.
Howard Hughes Medical Institute first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 42 quarters.
Howard Hughes Medical Institute's Thermo Fisher Scientific position peaked at $13.3M in Q4 2021.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.